HRA Pharma (now Perrigo)

Health & Healthtech · Consumer · Public Affairs · Corporate

Making contraception more accessible: Launching the UK's first OTC contraceptive pill

740+
earned media stories
14K
website visits
15 million
earned media reach
95%
market share

Challenge

How do you launch a breakthrough product that changes women’s healthcare forever?

For the first time since the contraceptive pill was introduced in 1961, UK women could access it without a prescription. But reclassifying a hormonal contraceptive as over the counter (OTC) risked controversy. To succeed, Hana needed smart planning, trusted voices and a campaign that could balance boldness with sensitivity, while beating its direct competitor to become the leading brand in a new category.

Approach

We launched Hello Hana. A confident, credible and culturally resonant campaign marking a historic moment in women’s health.

Backed by deep media and stakeholder insight, we built a four-phase strategy: map the landscape, mitigate risk, shape the narrative and build long-term credibility. With no prior notification of when the MHRA reclassification announcement would come, we set the beat, conducting embargoed pre-launch media briefings with 17 media medics and national health journalists so that when the news broke, Hana was embedded in the story. Ongoing earned media engagement and select paid partnerships helped drive positive awareness and cut-through, reinforcing Hana’s mission: to empower women through greater access to contraception.

Award win
Best pharmaceutical product launch (OTC) PR Week, Healthcare & Pharma

Impact

  • 748 launch media stories with a reach of 15+ million
  • 14K website visits and £6.5K in online sales in first month
  • 95% market share within two months
  • 97% share of voice in OTC launch media coverage
  • 99% positive or neutral sentiment